Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions
NCT00872833 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32
Last updated 2015-10-07
Summary
Thalassemia is an inherited blood disorder that can result in mild to severe anemia. Regular blood transfusions, which refresh the healthy red blood cell supply, are one treatment for thalassemia. People with thalassemia often experience pain, but the exact source of pain remains unknown. This study will examine how pain varies during the blood transfusion cycle in people with thalassemia who are treated with regular blood transfusions.
Conditions
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
Carelon Research
lead OTHER
Principal Investigators
-
Dru Foote, NP · Children's Hospital and Research Institute Oakland
-
Jeanne Boudreaux, MD · Children's Healthcare of Atlanta
-
Thomas Coates, MD · Children's Hospital Los Angeles
-
Elliott Vichinsky, MD · UCSF Benioff Children's Hospital Oakland
-
Michael Jeng, MD · Stanford University
-
Janet Kwiatkowski, MD · Children's Hospital of Philadelphia
-
Nancy Olivieri, MD · University Health Network - Toronto General Hospital
-
Patricia J. Giardina, MD · Weill Medical College of Cornell
-
Brigitta Mueller, MD · Baylor College of Medicine
-
Alexis A. Thompson, MD, MPH · Ann & Robert H Lurie Children's Hospital of Chicago
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2010-10-31
- Completion
- 2010-10-31
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Screening for Alpha Thalassemia in Healthy Volunteers
NCT02692872 ·Status: ACTIVE_NOT_RECRUITING
-
Detection of β Thalassemia Carriers by Red Cell Parameters Obtained From the H2 Automatic Counter
NCT00481221 ·Status: UNKNOWN
-
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
NCT00029380 ·Status: COMPLETED ·Phase: PHASE2
-
Bone Marrow for Hemoglobinopathy Research
NCT00669305 ·Status: COMPLETED
-
Deferoxamine for the Treatment of Hemochromatosis
NCT00001203 ·Status: COMPLETED
-
Long Term Outcomes in β Thalassemia Major
NCT02307786 ·Status: COMPLETED
-
Long-term Clinical Study of CN128 in Thalassemia Patients
NCT04614779 ·Status: COMPLETED ·Phase: PHASE2
-
Thalassemia Treatment Based on the Stem Cell Technology
NCT03222453 ·Status: UNKNOWN ·Phase: NA
-
Adherence of Beta Thalssemia Patients to Oral Chelation Therapy
NCT06568926 ·Status: RECRUITING ·Phase: NA
-
Assess the Feasibility and Safety of Granulocyte Colony Stimulating Factor (GCSF) Mobilization of CD34+ Hematopoietic Progenitor Cells in Patients With Betathalassemia Major
NCT00658385 ·Status: COMPLETED ·Phase: NA
-
Detection Of β-thalassemia Carriers In Assiut
NCT03822585 ·Status: UNKNOWN ·Phase: NA
-
Beta-thalassemia and Microparticles
NCT01284738 ·Status: COMPLETED ·Phase: NA
-
Demographic, Clinical, Laboratory and Genetical Characteristics of Patients With Beta Thalassemia Intermedia
NCT01443312 ·Status: COMPLETED
-
5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia
NCT00005934 ·Status: COMPLETED ·Phase: PHASE2
-
T2* in Transfusion Dependant Anemia, MI, LVF, Normal Patients
NCT00520559 ·Status: COMPLETED
-
Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy
NCT02633943 ·Status: ACTIVE_NOT_RECRUITING
-
Reproductive Capacity and Iron Burden in Thalassemia
NCT02308904 ·Status: COMPLETED ·Phase: NA
-
The Effective and Safety of Thalidomide in NTDT
NCT02995707 ·Status: UNKNOWN ·Phase: PHASE2
-
Effects of Transfusion of Older Stored Red Cells
NCT01534676 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)
NCT01996683 ·Status: UNKNOWN ·Phase: NA
-
Β-Thalassemia Treatment with KL003 Cell Injection
NCT06280378 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Reduced Intensity Transplant Conditioning Regimen for Severe Thalassemia
NCT01005576 ·Status: COMPLETED ·Phase: PHASE2
-
Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)
NCT00001958 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded Patients
NCT05355766 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis
NCT00171171 ·Status: COMPLETED ·Phase: PHASE3